Overview
- The White House signed the executive order on Aug. 10 directing HHS and FDA to reduce the set of routinely recommended childhood vaccines, reclassify several as 'shared clinical decision‑making,' and pursue separation of combination shots such as MMR.
- The order tells the attorney general to press legal challenges against state vaccine mandates and to condition federal funding on compliance, a move that states and medical groups say they will immediately fight in court.
- Public‑health experts and pediatric societies warn splitting combination vaccines and spacing doses would require many more doctor visits, raise costs, lower on‑time coverage and heighten the risk of outbreaks during a large 2026 measles resurgence.
- Manufacturers and former regulators say practical implementation faces major hurdles because single‑antigen measles, mumps and rubella vaccines are not licensed or made in the U.S., and developing new products and facilities plus securing FDA approvals would likely take years and large investment.
- The conflict pits a politically driven White House directive against established public‑health bodies and state authority, drawing unified criticism across medical organizations and news outlets and setting up a long legal and regulatory fight over who sets U.S. vaccine policy.